بدائل البحث:
significant decrease » significant increase (توسيع البحث), significantly increased (توسيع البحث)
clinical decrease » clinical disease (توسيع البحث), clinical case (توسيع البحث), linear decrease (توسيع البحث)
clinical cases » clinical care (توسيع البحث)
significant decrease » significant increase (توسيع البحث), significantly increased (توسيع البحث)
clinical decrease » clinical disease (توسيع البحث), clinical case (توسيع البحث), linear decrease (توسيع البحث)
clinical cases » clinical care (توسيع البحث)
-
21221
Table 5_Cost-effectiveness analysis of sugemalimab combined with chemotherapy as first-line treatment for advanced gastric cancer.xlsx
منشور في 2025"…</p>Results<p>The base-case analysis showed that the sugemalimab regimen provided greater health benefits compared to the placebo group (1.36 QALYs vs. 1.24 QALYs) but incurred significantly higher costs (271,041.24 CNY vs. 44,174.69 CNY), yielding an ICER of 1,890,554.58 CNY/QALY. …"
-
21222
Table 6_Cost-effectiveness analysis of sugemalimab combined with chemotherapy as first-line treatment for advanced gastric cancer.xls
منشور في 2025"…</p>Results<p>The base-case analysis showed that the sugemalimab regimen provided greater health benefits compared to the placebo group (1.36 QALYs vs. 1.24 QALYs) but incurred significantly higher costs (271,041.24 CNY vs. 44,174.69 CNY), yielding an ICER of 1,890,554.58 CNY/QALY. …"
-
21223
Table 1_Cost-effectiveness analysis of sugemalimab combined with chemotherapy as first-line treatment for advanced gastric cancer.doc
منشور في 2025"…</p>Results<p>The base-case analysis showed that the sugemalimab regimen provided greater health benefits compared to the placebo group (1.36 QALYs vs. 1.24 QALYs) but incurred significantly higher costs (271,041.24 CNY vs. 44,174.69 CNY), yielding an ICER of 1,890,554.58 CNY/QALY. …"
-
21224
Establishment and validation of the prognostic risk model based on the anoikis-related genes in esophageal squamous cell carcinoma
منشور في 2024"…The IC50 values of predicted drugs, in the case of Tozasertib 1096 and WIKI4 1940, were significantly variant between risk groups. …"
-
21225
Table 3_Cost-effectiveness analysis of sugemalimab combined with chemotherapy as first-line treatment for advanced gastric cancer.xls
منشور في 2025"…</p>Results<p>The base-case analysis showed that the sugemalimab regimen provided greater health benefits compared to the placebo group (1.36 QALYs vs. 1.24 QALYs) but incurred significantly higher costs (271,041.24 CNY vs. 44,174.69 CNY), yielding an ICER of 1,890,554.58 CNY/QALY. …"
-
21226
Table 9_Cost-effectiveness analysis of sugemalimab combined with chemotherapy as first-line treatment for advanced gastric cancer.xlsx
منشور في 2025"…</p>Results<p>The base-case analysis showed that the sugemalimab regimen provided greater health benefits compared to the placebo group (1.36 QALYs vs. 1.24 QALYs) but incurred significantly higher costs (271,041.24 CNY vs. 44,174.69 CNY), yielding an ICER of 1,890,554.58 CNY/QALY. …"
-
21227
Supplementary Material for: Generalized Pustular Psoriasis Confers Increased Risk of Pyoderma Gangrenosum: First Population-Based Evidence
منشور في 2025"…Results: After matching, the GPP cohort (n = 44,187) had a significantly higher risk of PG than controls (n = 44,187; HR 5.14; 95% CI 2.77–9.53). …"
-
21228
Table 2_Cost-effectiveness analysis of sugemalimab combined with chemotherapy as first-line treatment for advanced gastric cancer.xls
منشور في 2025"…</p>Results<p>The base-case analysis showed that the sugemalimab regimen provided greater health benefits compared to the placebo group (1.36 QALYs vs. 1.24 QALYs) but incurred significantly higher costs (271,041.24 CNY vs. 44,174.69 CNY), yielding an ICER of 1,890,554.58 CNY/QALY. …"
-
21229
Data Sheet 1_Circulating tsRNAs serve as potential biomarkers for predicting postoperative delirium in elderly patients receiving lower extremity orthopedic surgery.docx
منشور في 2025"…</p>Methods<p>This study conducted a prospective case-control study of 158 elderly patients (≥60 years) undergoing orthopedic surgery. …"
-
21230
Table 7_Cost-effectiveness analysis of sugemalimab combined with chemotherapy as first-line treatment for advanced gastric cancer.xls
منشور في 2025"…</p>Results<p>The base-case analysis showed that the sugemalimab regimen provided greater health benefits compared to the placebo group (1.36 QALYs vs. 1.24 QALYs) but incurred significantly higher costs (271,041.24 CNY vs. 44,174.69 CNY), yielding an ICER of 1,890,554.58 CNY/QALY. …"
-
21231
Table 1_Characterization of Photobacterium damselae subsp. damselae isolated from a spotted seal (Phoca largha) (Pinnipedia: Phocidae) stranded in Korea.docx
منشور في 2025"…</p>Methods<p>We report the first case of systemic infection caused by PDD in a free-ranging spotted seal (Phoca largha) stranded in Korea. …"
-
21232
Table 4_Cost-effectiveness analysis of sugemalimab combined with chemotherapy as first-line treatment for advanced gastric cancer.xlsx
منشور في 2025"…</p>Results<p>The base-case analysis showed that the sugemalimab regimen provided greater health benefits compared to the placebo group (1.36 QALYs vs. 1.24 QALYs) but incurred significantly higher costs (271,041.24 CNY vs. 44,174.69 CNY), yielding an ICER of 1,890,554.58 CNY/QALY. …"
-
21233
External factors associated with CHWs’ technology acceptance and usage.
منشور في 2025"…<p>Panels (a–c) show how CHWs’ clinical engagement varies by smartphone access and usage. a: The graph illustrates the percentage of CHWs who had experienced the management of each community health case. b: CHWs who have their own smartphones had managed significantly higher number of conditions. …"
-
21234
Behavioral characterization of prenatal nicotine exposure (PNE) and control mice.
منشور في 2025"…Quantification of the average total distance traveled. Significant differences were observed between PNE animals and control mice (PNE: 78.37 ± 2.01 m; n = 6; Control = 51.57 ± 3.33 m; n = 6), t = 6,883 df = 10, p < 0,0001. …"
-
21235
The effect of inulin treatment on plasma untargeted metabolomic profiles in mice of diverse groups.
منشور في 2025"…Color key in the heat map represents the metabolite expression value: red represents the significant increases and blue stands for the remarkable decreases. …"
-
21236
Table3_Aconitate decarboxylase 1 mediates the acute airway inflammatory response to environmental exposures.docx
منشور في 2024"…</p>Results<p>Acod1<sup>−/−</sup> mice treated with LPS demonstrated decreased BALF levels of itaconate, TCA cycle reprogramming, decreased BALF neutrophils, increased lung CD4<sup>+</sup> T cells, decreased BALF and lung levels of TNF-α, and decreased BALF CXCL1 compared to WT animals. …"
-
21237
Image1_Aconitate decarboxylase 1 mediates the acute airway inflammatory response to environmental exposures.jpeg
منشور في 2024"…</p>Results<p>Acod1<sup>−/−</sup> mice treated with LPS demonstrated decreased BALF levels of itaconate, TCA cycle reprogramming, decreased BALF neutrophils, increased lung CD4<sup>+</sup> T cells, decreased BALF and lung levels of TNF-α, and decreased BALF CXCL1 compared to WT animals. …"
-
21238
Table1_Aconitate decarboxylase 1 mediates the acute airway inflammatory response to environmental exposures.docx
منشور في 2024"…</p>Results<p>Acod1<sup>−/−</sup> mice treated with LPS demonstrated decreased BALF levels of itaconate, TCA cycle reprogramming, decreased BALF neutrophils, increased lung CD4<sup>+</sup> T cells, decreased BALF and lung levels of TNF-α, and decreased BALF CXCL1 compared to WT animals. …"
-
21239
Table2_Aconitate decarboxylase 1 mediates the acute airway inflammatory response to environmental exposures.docx
منشور في 2024"…</p>Results<p>Acod1<sup>−/−</sup> mice treated with LPS demonstrated decreased BALF levels of itaconate, TCA cycle reprogramming, decreased BALF neutrophils, increased lung CD4<sup>+</sup> T cells, decreased BALF and lung levels of TNF-α, and decreased BALF CXCL1 compared to WT animals. …"
-
21240
Image3_Aconitate decarboxylase 1 mediates the acute airway inflammatory response to environmental exposures.jpeg
منشور في 2024"…</p>Results<p>Acod1<sup>−/−</sup> mice treated with LPS demonstrated decreased BALF levels of itaconate, TCA cycle reprogramming, decreased BALF neutrophils, increased lung CD4<sup>+</sup> T cells, decreased BALF and lung levels of TNF-α, and decreased BALF CXCL1 compared to WT animals. …"